botulinum toxin A


Also found in: Dictionary, Thesaurus.
Related to botulinum toxin A: Botox, Botulinum toxin type a

botulinum toxin A

Oculinum Neurology One of several toxins produced by C botulinum, of which the 150 kD type A toxin has been purified and used to treat various neuromuscular junction disorders including strabismus, blepharospasm, spasmodic torticollis, other dystonias, hemifacial spasms, and anal incontinence
References in periodicals archive ?
of the Medical College of Wisconsin, Milwaukee, and colleagues performed a review and meta-analysis to assess the association of botulinum toxin A with reducing headache frequency when used for preventive treatment of migraine, tension, or chronic daily headaches in adults.
Treatment of gustatory sweating (Frey's syn-drome) with botulinum toxin A.
Botulinum toxin as a biological weapon: Medical and public health management.
Dr Mario Patricolo, Consultant paediatric surgeon and paediatric urologist at SKMC performed the first procedures of botulinum toxin A injection into the bladders of the three children.
Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
Effect of botulinum toxin A injec-tions in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial.
Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study.
This assortment of strains, labeled botulinum toxin A through G, produces seven related, yet distinct toxins.
Ipsen's botulinum toxin Type A is approved for cosmetic indications in 10 countries: Argentina, Brazil, Columbia, Honduras, New Zealand, Uruguay, Ukraine, Vietnam, Mexico and Russia (in Russia, it is the first botulinum toxin A approved in this field).
Although botulinum toxin as a cosmetic treatment is growing in success year upon year, its future is not all about appearances, as the Carruthers stressed in a recent interview with SonntagsZeitung: "Toxins can change the world and really improve people's lives.
In December, 1989, the FDA licensed botulinum toxin as an orphan drug, thus recognizing it for human treatment.